Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance. Aldred KJ, McPherson SA, Turnbough CL, Kerns RJ, Osheroff N (2013) Nucleic Acids Res 41: 4628-39 Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV. Pitts SL, Liou GF, Mitchenall LA, Burgin AB, Maxwell A, Neuman KC, Osheroff N (2011) Nucleic Acids Res 39: 4808-17 Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions. Aldred KJ, Schwanz HA, Li G, McPherson SA, Turnbough CL, Kerns RJ, Osheroff N (2013) ACS Chem Biol 8: 2660-8 Topoisomerase IV catalysis and the mechanism of quinolone action. Anderson VE, Gootz TD, Osheroff N (1998) J Biol Chem 273: 17879-85 Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism across evolutionary boundaries. Anderson VE, Zaniewski RP, Kaczmarek FS, Gootz TD, Osheroff N (1999) J Biol Chem 274: 35927-32 NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy. Dougherty TJ, Nayar A, Newman JV, Hopkins S, Stone GG, Johnstone M, Shapiro AB, Cronin M, Reck F, Ehmann DE (2014) Antimicrob Agents Chemother 58: 2657-64 Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Aldred KJ, McPherson SA, Wang P, Kerns RJ, Graves DE, Turnbough CL, Osheroff N (2012) Biochemistry 51: 370-81 Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement. Anderson VE, Zaniewski RP, Kaczmarek FS, Gootz TD, Osheroff N (2000) Biochemistry 39: 2726-32 Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. Anderson VE, Osheroff N (2001) Curr Pharm Des 7: 337-53
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.